Antiviral Activity and Resistance Emergence: Combinations of the NS5B Nucleotide Inhibitor ACH-3422 with Other Antiviral Agents in Vitro

Conference Reports for NATAP

65th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 7-11 2014


Antiviral Activity and Resistance Emergence: Combinations of the NS5B Nucleotide Inhibitor ACH-3422 with Other Antiviral Agents in Vitro

	Reported by Jules Levin AASLD 2014 Nov 7-11 Boston Dharaben Patel, Yongsen Zhao, Joanne Fabrycki, Guangwei Yang, Steven Podos, Jason Wiles, Avinash Phadke, Mingjun Huang and Wengang Yang